Larry Todd Edwards - 30 Nov 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Reporting Person's title: Executive Vice President Chief Commercial Officer
Signature: /s/ David Topper, as Attorney-in-Fact for Larry Todd Edwards
Issuer symbol: ARQT
Transactions as of: 30 Nov 2024
Transactions value $: $7,767
Form type: 4
Filing time: 03 Dec 2024, 16:17:09 UTC
Previous filing: 03 Oct 2024
Next filing: 04 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Purchase	$7.77K	+1.09K	+0.8%	$7.11	138K	30 Nov 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the purchase transaction of the Company's Employee Stock Purchase Plan.

Remarks:

Reporting Person's title: Executive Vice President Chief Commercial Officer